Walgreens Boots Alliance Inc. [NASDAQ:WBA] is seeing significant action in the Healthcare space. WBA stock has price per sales of 0.23 and price per cash flow of 11.74. The company is also booking 0.82 earnings per share.
The tape is active for Walgreens Boots Alliance Inc. [WBA] and the current price target sits at $40.28.
To add more color to this price target, WBA’s high over the last year is $46.00 and the low is $33.00. Over the last two 52 weeks, the company is trading -29.95%, while the S&P 500 is trading 0.55%.
Wait and see
Holding a Market Cap of $31.71 billion, Walgreens Boots Alliance Inc. has seen a trading range over the last year of $33.88-$64.50.
For the last five days, WBA is up from its last closing price. The average shares trading hands each day is 6.75M, with average 10-day volume coming in at 5.19 million.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for WBA. When we apply the Elder Force Index to Walgreens Boots Alliance Inc., we are seeing an Elder Force Indicator number of 339621.04.
The recent performance of the stock is another area that can tell traders how to proceed. WBA is presenting an interesting case. This can be seen in the Forward P/E ratio, which currently stands at 7.37. Moreover, the company’s enterprise value has gone from $77.72B to $80.76B quarter-over-quarter. This could be an inflection point for the company, but either way we believe you should be adding them to your watchlist.
In the last quarter, WBA made a profit of 6.44 billion. Walgreens Boots Alliance Inc. also saw quarter revenue growth year over year of 4.05%. In addition, the company has operating cash flow of $5.78 billion.
Looking at popular technical indicators, the company’s 5-day moving average is 36.37 compared to the 50-day moving average of 36.80. So, traders might want to tread carefully if they are going to bid.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. WBA currently holds a 9-day RSI of 59.83%, while 100-day RSI stands at 45.84%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. WBA’s 9-day MACD is 0.37 and the company’s 100-day MACD stands at -3.46.
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 22.25% by insiders and 60.61% by institutions. Regarding institutional holdings, Vanguard Group, Inc. (The) owns 7.00%, while the second top holder, Blackrock Inc., currently owns 6.03%.
Over the last six months, insiders have sold 234,355 with the most recent transaction from Pagni Marco Patrick Anthony, EVP, Global CAO and GC, with a sell at price 63.16 per share.
Overall, the recommended rating for WBA is Hold. Currently, the company has 19 analysts watching the stock, and the average quarterly earnings estimate is 0.96. Quarterly revenue estimates are averaging 34.55B with the high estimate reaching 36.7B and the low at 33.34B.
To review, the current 1-year target estimate is sitting at 40.94, while the current price 36.93. Based on this, we expect the stock to rise considering the aforementioned fundamentals.